<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Amending Schedules</p><ul class="Section ProvisionList" id="412382"><li><p class="Subsection" id="412384"><strong><a class="sectionLabel" id="s-21.03"><span class="sectionLabel">21.03</span></a></strong> <span class="lawlabel">(1)</span> The Governor in Council may, by order,</p><ul class="ProvisionList"><li><p class="Paragraph" id="412385"><span class="lawlabel">(a)</span> on the recommendation of the Minister and the Minister of Health, amend Schedule 1</p><ul class="ProvisionList"><li><p class="Subparagraph" id="412386"><span class="lawlabel">(i)</span> by adding the name of any patented product that may be used to address public health problems afflicting many developing and least-developed countries, especially those resulting from HIV/AIDS, tuberculosis, malaria and other epidemics and, if the Governor in Council considers it appropriate to do so, by adding one or more of the following in respect of the patented product, namely, a dosage form, a strength and a route of administration, and</p></li><li><p class="Subparagraph" id="412387"><span class="lawlabel">(ii)</span> by removing any entry listed in it;</p></li></ul></li><li><p class="Paragraph" id="412388"><span class="lawlabel">(b)</span> on the recommendation of the Minister of Foreign Affairs, the Minister for International Trade and the Minister for International Development, amend Schedule 2 by adding the name of any country recognized by the United Nations as being a least-developed country that has,</p><ul class="ProvisionList"><li><p class="Subparagraph" id="412389"><span class="lawlabel">(i)</span> if it is a WTO Member, provided the TRIPS Council with a notice in writing stating that the country intends to import, in accordance with the General Council Decision, pharmaceutical products, as defined in paragraph 1(a) of that decision, and</p></li><li><p class="Subparagraph" id="412390"><span class="lawlabel">(ii)</span> if it is not a WTO Member, provided the Government of Canada with a notice in writing through diplomatic channels stating that the country intends to import pharmaceutical products, as defined in paragraph 1(a) of the General Council Decision, that it agrees that those products will not be used for commercial purposes and that it undertakes to adopt the measures referred to in Article 4 of that decision;</p></li></ul></li><li><p class="Paragraph" id="412391"><span class="lawlabel">(c)</span> on the recommendation of the Minister of Foreign Affairs, the Minister for International Trade and the Minister for International Development, amend Schedule 3 by adding the name of any WTO Member not listed in Schedule 2 that has provided the TRIPS Council with a notice in writing stating that the WTO Member intends to import, in accordance with the General Council Decision, pharmaceutical products, as defined in paragraph 1(a) of that decision; and</p></li><li><p class="Paragraph" id="412392"><span class="lawlabel">(d)</span> on the recommendation of the Minister of Foreign Affairs, the Minister for International Trade and the Minister for International Development, amend Schedule 4 by adding the name of</p><ul class="ProvisionList"><li><p class="Subparagraph" id="412393"><span class="lawlabel">(i)</span> any WTO Member not listed in Schedule 2 or 3 that has provided the TRIPS Council with a notice in writing stating that the WTO Member intends to import, in accordance with the General Council Decision, pharmaceutical products, as defined in paragraph 1(a) of that decision, or</p></li><li><p class="Subparagraph" id="412394"><span class="lawlabel">(ii)</span> any country that is not a WTO Member and that is named on the Organization for Economic Co-operation and Development’s list of countries that are eligible for official development assistance and that has provided the Government of Canada with a notice in writing through diplomatic channels</p><ul class="ProvisionList"><li><p class="Clause" id="412395"><span class="lawlabel">(A)</span> stating that it is faced with a national emergency or other circumstances of extreme urgency,</p></li><li><p class="Clause" id="412396"><span class="lawlabel">(B)</span> specifying the name of the pharmaceutical product, as defined in paragraph 1(a) of the General Council Decision, and the quantity of that product, needed by the country to deal with the emergency or other urgency,</p></li><li><p class="Clause" id="412397"><span class="lawlabel">(C)</span> stating that it has no, or insufficient, pharmaceutical capacity to manufacture that product, and</p></li><li><p class="Clause" id="412398"><span class="lawlabel">(D)</span> stating that it agrees that that product will not be used for commercial purposes and that it undertakes to adopt the measures referred to in Article 4 of the General Council Decision.</p></li></ul></li></ul></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Restriction - Schedule 3</p><p class="Subsection" id="412399"><span class="lawlabel">(2)</span> The Governor in Council may not add to Schedule 3 the name of any WTO Member that has notified the TRIPS Council that it will import, in accordance with the General Council Decision, pharmaceutical products, as defined in paragraph 1(a) of that decision, only if faced with a national emergency or other circumstances of extreme urgency.</p></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Removal from Schedules 2 to 4</p><p class="Subsection" id="412401"><span class="lawlabel">(3)</span> The Governor in Council may, by order, on the recommendation of the Minister of Foreign Affairs, the Minister for International Trade and the Minister for International Development, amend any of Schedules 2 to 4 to remove the name of any country or WTO Member if</p><ul class="ProvisionList"><li><p class="Paragraph" id="412403"><span class="lawlabel">(a)</span> in the case of a country or WTO Member listed in Schedule 2, the country or WTO Member has ceased to be recognized by the United Nations as being a least-developed country or, in the case of a country that is not a WTO Member, the country has permitted any product imported into that country under an authorization to be used for commercial purposes or has failed to adopt the measures referred to in Article 4 of the General Council Decision;</p></li><li><p class="Paragraph" id="412404"><span class="lawlabel">(b)</span> in the case of a WTO Member listed in Schedule 3, the WTO Member has notified the TRIPS Council that it will import, in accordance with the General Council Decision, pharmaceutical products, as defined in paragraph 1(a) of that decision, only if faced with a national emergency or other circumstances of extreme urgency;</p></li><li><p class="Paragraph" id="412405"><span class="lawlabel">(c)</span> in the case of a WTO Member listed in Schedule 4, the WTO Member has revoked any notification it has given to the TRIPS Council that it will import pharmaceutical products, as defined in paragraph 1(a) of the General Council Decision, only if faced with a national emergency or other circumstances of extreme urgency;</p></li><li><p class="Paragraph" id="412406"><span class="lawlabel">(d)</span> in the case of a country listed in Schedule 4 that is not a WTO Member,</p><ul class="ProvisionList"><li><p class="Subparagraph" id="412407"><span class="lawlabel">(i)</span> the name of the country is no longer on the Organization for Economic Co-operation and Development’s list of countries that are eligible for official development assistance,</p></li><li><p class="Subparagraph" id="412408"><span class="lawlabel">(ii)</span> the country no longer faces a national emergency or other circumstances of extreme urgency,</p></li><li><p class="Subparagraph" id="412409"><span class="lawlabel">(iii)</span> the country has permitted any product imported into that country under an authorization to be used for commercial purposes, or</p></li><li><p class="Subparagraph" id="412410"><span class="lawlabel">(iv)</span> the country has failed to adopt the measures referred to in Article 4 of the General Council Decision;</p></li></ul></li><li><p class="Paragraph" id="412411"><span class="lawlabel">(e)</span> in the case of any country or WTO Member listed in Schedule 3 or 4, the country or WTO Member has become recognized by the United Nations as a least-developed country; and</p></li><li><p class="Paragraph" id="412412"><span class="lawlabel">(f)</span> in the case of any country or WTO Member listed in any of Schedules 2 to 4, the country has notified the Government of Canada, or the WTO Member has notified the TRIPS Council, that it will not import pharmaceutical products, as defined in paragraph 1(a) of the General Council Decision.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Timeliness of orders</p><p class="Subsection" id="412413"><span class="lawlabel">(4)</span> An order under this section shall be made in a timely manner.</p></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">2004, c. 23, s. 1</li><li class="HistoricalNoteSubItem"> 2013, c. 33, s. 196</li></ul></div>